Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q425681> ?p ?o }
Showing triples 1 to 79 of
79
with 100 triples per page.
- Q425681 subject Q52359.
- Q425681 subject Q7211328.
- Q425681 subject Q8493005.
- Q425681 subject Q8556405.
- Q425681 subject Q8805811.
- Q425681 abstract "Lenalidomide /ˌlɛnəˈlɪdoʊmaɪd/ (trade name Revlimid) is a derivative of thalidomide introduced in 2004.It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). Along with several other drugs developed in recent years, lenalidomide has significantly improved overall survival in myeloma (which formerly carried a poor prognosis), although toxicity remains an issue for users. It costs $163,381 per year for the average patient.".
- Q425681 atcPrefix "L04".
- Q425681 atcSuffix "AX04".
- Q425681 casNumber "191732-72-6".
- Q425681 drugbank "DB00480".
- Q425681 fdaUniiCode "F0P408N6V4".
- Q425681 iupacName "(RS)-3-(4-Amino-1-oxo 1,3-dihydro-2H-isoindol- 2-yl)piperidine-2,6-dione".
- Q425681 pubchem "216326".
- Q425681 thumbnail Lenalidomide2DACS2.svg?width=300.
- Q425681 wikiPageExternalLink 3.08.02.html.
- Q425681 wikiPageExternalLink main.jsp?source=link&source_link_id=2048&type=article&tab_id=13&menu_id=94&id=1706.
- Q425681 wikiPageExternalLink www.revlimid.com.
- Q425681 wikiPageExternalLink REVLIMID_PI.pdf.
- Q425681 wikiPageWikiLink Q1053948.
- Q425681 wikiPageWikiLink Q1057079.
- Q425681 wikiPageWikiLink Q1088156.
- Q425681 wikiPageWikiLink Q1138590.
- Q425681 wikiPageWikiLink Q130146.
- Q425681 wikiPageWikiLink Q1349821.
- Q425681 wikiPageWikiLink Q1435822.
- Q425681 wikiPageWikiLink Q14599311.
- Q425681 wikiPageWikiLink Q166231.
- Q425681 wikiPageWikiLink Q1762339.
- Q425681 wikiPageWikiLink Q18936.
- Q425681 wikiPageWikiLink Q203174.
- Q425681 wikiPageWikiLink Q204711.
- Q425681 wikiPageWikiLink Q209369.
- Q425681 wikiPageWikiLink Q220570.
- Q425681 wikiPageWikiLink Q2298283.
- Q425681 wikiPageWikiLink Q2509220.
- Q425681 wikiPageWikiLink Q261327.
- Q425681 wikiPageWikiLink Q2751330.
- Q425681 wikiPageWikiLink Q30.
- Q425681 wikiPageWikiLink Q3271540.
- Q425681 wikiPageWikiLink Q33525.
- Q425681 wikiPageWikiLink Q3425168.
- Q425681 wikiPageWikiLink Q415939.
- Q425681 wikiPageWikiLink Q419319.
- Q425681 wikiPageWikiLink Q422252.
- Q425681 wikiPageWikiLink Q424381.
- Q425681 wikiPageWikiLink Q4381253.
- Q425681 wikiPageWikiLink Q467635.
- Q425681 wikiPageWikiLink Q52359.
- Q425681 wikiPageWikiLink Q5282007.
- Q425681 wikiPageWikiLink Q574834.
- Q425681 wikiPageWikiLink Q585285.
- Q425681 wikiPageWikiLink Q631521.
- Q425681 wikiPageWikiLink Q7211328.
- Q425681 wikiPageWikiLink Q828410.
- Q425681 wikiPageWikiLink Q8493005.
- Q425681 wikiPageWikiLink Q8556405.
- Q425681 wikiPageWikiLink Q864868.
- Q425681 wikiPageWikiLink Q8805811.
- Q425681 wikiPageWikiLink Q898317.
- Q425681 wikiPageWikiLink Q9377.
- Q425681 wikiPageWikiLink Q954625.
- Q425681 wikiPageWikiLink Q9618.
- Q425681 wikiPageWikiLink Q974135.
- Q425681 atcPrefix "L04".
- Q425681 atcSuffix "AX04".
- Q425681 casNumber "191732".
- Q425681 drugbank "DB00480".
- Q425681 iupacName "-3".
- Q425681 pubchem "216326".
- Q425681 unii "F0P408N6V4".
- Q425681 type ChemicalSubstance.
- Q425681 type Drug.
- Q425681 type ChemicalObject.
- Q425681 type Thing.
- Q425681 type Q8386.
- Q425681 comment "Lenalidomide /ˌlɛnəˈlɪdoʊmaɪd/ (trade name Revlimid) is a derivative of thalidomide introduced in 2004.It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS).".
- Q425681 label "Lenalidomide".
- Q425681 depiction Lenalidomide2DACS2.svg.
- Q425681 homepage www.revlimid.com.